Literature DB >> 18313513

Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia.

Fu-Der Wang1, Yin-Yin Chen, Te-Li Chen, Cheng-Yi Liu.   

Abstract

BACKGROUND: Infections due to methicillin-resistant Staphylococcus aureus have become increasingly common in hospitals worldwide. S aureus continues to be a cause of nosocomial bacteremia.
METHODS: We analyzed the clinical significance (mortality) of MRSA and methicillin-susceptible S aureus bacteremia in a retrospective cohort study in a 2900-bed tertiary referral medical center. Survival and logistic regression analyses were used to determine the risk factors and prognostic factors of mortality.
RESULTS: During the 15-year period, 1148 patients were diagnosed with nosocomial S aureus bacteremia. After controlling potential risk factors for MRSA bacteremia on logistic regression analysis, service, admission days prior to bacteremia, age, mechanical ventilator, and central venous catheter (CVC) were independent risk factors for MRSA. The crude mortality rate of S aureus bacteremia was 44.1%. The difference between the mortality rates of MRSA (49.8%) and MSSA bacteremia (27.6%) was 22.2% (P < .001). Upon logistic regression analysis, the mortality with MRSA bacteremia was revealed to be 1.78 times higher than MSSA (P < .001). The other predicted prognostic factors included age, neoplasms, duration of hospital stay after bacteremia, presence of mechanical ventilator, and use of CVC.
CONCLUSIONS: Resistance to methicillin was an important independent prognostic factor for patients with S aureus bacteremia.

Entities:  

Mesh:

Year:  2008        PMID: 18313513     DOI: 10.1016/j.ajic.2007.02.005

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  24 in total

1.  Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study.

Authors:  Ram Venkatesh Anantha; Januvi Jegatheswaran; Daniel Luke Pepe; Fran Priestap; Johan Delport; S M Mansour Haeryfar; John K McCormick; Tina Mele
Journal:  CMAJ Open       Date:  2014-10-01

2.  Methicillin-resistant Staphylococcus aureus in surgical patients: identification of high-risk populations for the development of targeted screening programmes.

Authors:  Stephanie Fraser; Richard R Brady; Catriona Graham; Simon Paterson-Brown; Alan P Gibb
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

3.  Septic pulmonary embolism associated with a peri-proctal abscess in an immunocompetent host.

Authors:  Enting Chang; Kuo-Hsien Lee; Kuang-Yao Yang; Yu-Chin Lee; Reury-Perng Perng
Journal:  BMJ Case Rep       Date:  2009-02-26

4.  Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study.

Authors:  G Sasson; A D Bai; A Showler; L Burry; M Steinberg; D R Ricciuto; T Fernandes; A Chiu; S Raybardhan; M Science; E Fernando; A M Morris; C M Bell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-01       Impact factor: 3.267

5.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

6.  Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007.

Authors:  Hassanain I Al-Talib; Chan Y Yean; Karim Al-Jashamy; Habsah Hasan
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

7.  Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA.

Authors:  Jingru Meng; Hui Wang; Zheng Hou; Tao Chen; Jingguo Fu; Xue Ma; Gonghao He; Xiaoyan Xue; Min Jia; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

8.  Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Kenneth P Tai; Karishma Kamdar; Jason Yamaki; Valerie V Le; Dat Tran; Patti Tran; Michael E Selsted; André J Ouellette; Annie Wong-Beringer
Journal:  Innate Immun       Date:  2013-12-17       Impact factor: 2.680

9.  Antimicrobial Peptide P60.4Ac-Containing Creams and Gel for Eradication of Methicillin-Resistant Staphylococcus aureus from Cultured Skin and Airway Epithelial Surfaces.

Authors:  Elisabeth M Haisma; Anikó Göblyös; Bep Ravensbergen; Alwin E Adriaans; Robert A Cordfunke; Jasmijn Schrumpf; Ronald W A L Limpens; Kirsten J M Schimmel; Jan den Hartigh; Pieter S Hiemstra; Jan Wouter Drijfhout; Abdoelwaheb El Ghalbzouri; Peter H Nibbering
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs.

Authors:  Meredith C Faires; Michelle Traverse; Kathy C Tater; David L Pearl; J Scott Weese
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.